
The Durbin Amendment Ensures Research Funding Rema...
The Peer Reviewed Cancer Research Program at the Department of Defense (DoD) has led to many significant discoveries and innovative new treatments for advanced melanoma. Ho...
Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
The Peer Reviewed Cancer Research Program at the Department of Defense (DoD) has led to many significant discoveries and innovative new treatments for advanced melanoma. Ho...
The Two Largest Nonprofit Funders of Melanoma Research Applaud Committee’s Ongoing Support and Dedication to Advancing Breakthrough Melanoma Research WASHINGTON, DC &...
White Paper Seeks to Build on Progress of Last 10 Years Washington, DC – Recently the Melanoma Research Foundation (MRF) convened a summit of internationally-r...
Melanoma has been a part of my life since 2004. November 2004 I was diagnosed with Stage I cutaneous (skin) melanoma and in January 2008 I was diagnosed with ocular melanom...
I was first diagnosed with melanoma in 1996. Thanks to my primary care doctor, who identified an irregular mole on my back during a routine physical, and my dermatologist, ...
Through the Melanoma Research Foundation’s #CUREOM Unite! Campaign, Ocular Melanoma Patients Help Fund and Review Research Grant Washington, DC – T...
#GivingTuesday is almost over but it’s not too late to give a gift to the Melanoma Research Foundation (MRF) to help stop melanoma in its path. Christy and Dan share why ...
Today is #GivingTuesday! Read why Carola Supports the MRF. Melanoma is one of the fastest growing cancers in the world. Today, however, people across the globe stand...
#GivingTuesday is TOMORROW, December 1! Join Graham in Supporting the MRF. During the holiday season, we are especially grateful for the children in our lives and th...
#GivingTuesday is Tuesday, December 1, 2015! Join Julie and Amelia in Supporting the MRF. #GivingTuesday is Tuesday, December 1 and your gift to the Melanoma Researc...
Today, the FDA approved the targeted therapy combination of vemurafenib (Zelboraf®) with cobimetinib (Cotellic) for people who have advanced or metastatic melanoma and who...
Washington, D.C. – On Saturday, November 7th, the Washington, D.C. melanoma community will come together to honor those who have been impacted by melanoma and raise f...
Oct 16, 2025 ET
Oct 30, 2025 ET